Your browser doesn't support javascript.
loading
An Inhaled PI3Kδ Inhibitor Improves Recovery in Acutely Exacerbating COPD Patients: A Randomized Trial.
Cahn, Anthony; Hamblin, J Nicole; Robertson, Jon; Begg, Malcolm; Jarvis, Emily; Wilson, Robert; Dear, Gordon; Leemereise, Claudia; Cui, Yi; Mizuma, Maki; Montembault, Mickael; Van Holsbeke, Cedric; Vos, Wim; De Backer, Wilfried; De Backer, Jan; Hessel, Edith M.
Afiliación
  • Cahn A; Discovery Medicine, GlaxoSmithKline, Stevenage, UK.
  • Hamblin JN; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.
  • Robertson J; Biostatistics, GlaxoSmithKline, Stevenage, UK.
  • Begg M; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.
  • Jarvis E; Biostatistics, GlaxoSmithKline, Stevenage, UK.
  • Wilson R; Discovery Medicine, GlaxoSmithKline, Stevenage, UK.
  • Dear G; Mechanistic Safety & Disposition, GlaxoSmithKline, Ware, UK.
  • Leemereise C; Global Clinical Sciences & Delivery, GlaxoSmithKline, Amersfoort, the Netherlands.
  • Cui Y; Pharma Safety, GlaxoSmithKline, Brentford, Middlesex, UK.
  • Mizuma M; Data Management & Strategy, GlaxoSmithKline, Tokyo, Japan.
  • Montembault M; Global Clinical Sciences & Delivery, GlaxoSmithKline, Brentford, Middlesex, UK.
  • Van Holsbeke C; FLUIDDA nv, Kontich, 2550, Belgium.
  • Vos W; FLUIDDA nv, Kontich, 2550, Belgium.
  • De Backer W; Pulmonary Medicine & Pulmonary Rehabilitation, University of Antwerp, Antwerp, Belgium.
  • De Backer J; FLUIDDA nv, Kontich, 2550, Belgium.
  • Hessel EM; Refractory Respiratory Inflammation Discovery Performance Unit, GlaxoSmithKline, Stevenage, UK.
Int J Chron Obstruct Pulmon Dis ; 16: 1607-1619, 2021.
Article en En | MEDLINE | ID: mdl-34113093

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Fosfatidilinositol 3-Quinasas / Enfermedad Pulmonar Obstructiva Crónica Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Int J Chron Obstruct Pulmon Dis Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido